Trial Profile
Multicenter, randomized, open label trial comparing the efficacy and safety of a basiliximab-based immunosuppressive regimen, immediate introduction of small doses of extended-release tacrolimus, mycophenolate sodium and steroids versus basiliximab, delayed introduction of small doses of extended-release tacrolimus, mycophenolate sodium and steroids in elderly patients with kidney transplants. [Ensayo multicéntrico, aleatorizado, abierto que compara la eficacia y seguridad de un régimen inmunosupresor basado en basiliximab, introducción inmediata de dosis reducidas de tacrolimus de liberación prolongada, micofenolato sódico y esteroides versus basiliximab, introducción retardada de dosis reducidas de tacrolimus de liberación prolongada, micofenolato sódico y esteroides en pacientes añosos trasplantados renales.]
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2013
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Basiliximab; Corticosteroids; Mycophenolate sodium
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 13 Aug 2013 Status changed from recruiting to discontinued.
- 14 Oct 2011 New trial record